查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1414538

2024 年全球呼吸系統疾病檢測市場報告

Respiratory Disease Testing Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，呼吸道疾病檢測的市場規模一直在穩定成長。將從2023年的34.2億美元擴大到2024年的35.8億美元，複合年成長率為4.6%。過去一段時間的擴張是由多種因素造成的，包括環境問題和污染、吸煙流行、職業呼吸道危害、意識提升宣傳活動和健康教育計劃。此外，政府在疾病控制方面的努力在塑造這段時期的成長格局方面發揮了關鍵作用。

預計未來幾年呼吸系統疾病檢測的市場規模將穩定成長。 2028年，將以4.8%的年複合成長率（CAGR）成長至43.1億美元。預測期內的成長是由幾個關鍵因素推動的，包括空氣傳播的呼吸道病毒的增加、對家庭檢測解決方案的重視、精準醫學研究的增加、持續的環境健康問題以及對早期療育和預防的重視。然後再考慮。在此期間預計的顯著趨勢包括採用現場護理測試、人工智慧 (AI) 整合、遠端監控技術的利用、遠端醫療服務的擴展、客製化生物標記物面板的開發以及包括增強功能到分析技術。

隨著呼吸系統疾病盛行率的上升，呼吸系統疾病檢測市場預計在可預見的未來將大幅擴大。呼吸系統疾病包括影響呼吸系統的病症，包括肺部、支氣管、氣管、喉、咽和鼻道。呼吸道疾病檢測的主要目的是早期發現和診斷，以及及時治療和管理。這種積極主動的方法不僅對於預防疾病進展至關重要，而且對於限制傳染性呼吸道疾病的傳播和降低併發症的風險也至關重要。例如，根據非傳染性疾病聯盟2022年9月發布的資料，肺癌是全球癌症死亡的主要原因，預計每年新增病例220萬，死亡人數180萬。慢性呼吸道疾病影響全球5.5億成年人，造成420萬人死亡，佔總數的7%。因此，呼吸系統疾病盛行率的上升是呼吸系統疾病檢測市場的主要促進因素。

吸煙率的上升預計將進一步推動呼吸道疾病檢測市場的成長。由於吸入燃燒乾菸葉產生的煙霧，吸煙會對您的呼吸道健康產生重大影響。呼吸道疾病檢測已成為吸菸者照護的重要組成部分，使醫療保健專業人員能夠監測肺功能隨時間的變化。這種監測可以幫助您評估戒菸努力的有效性並相應地調整您的治療計劃。例如，根據美國疾病管制與預防中心2023年5月發布的資料，2021年美國約2830萬18歲以上成年人吸煙，約1600萬美國吸煙。與吸煙有關的疾病。因此，吸菸的增加是呼吸道疾病檢測市場擴大的驅動力。

2023年，北美成為呼吸系統疾病檢測市場最大的地區。預計亞太地區將成為預測期內全球呼吸道疾病檢測市場成長最快的地區。呼吸道疾病檢測市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球市場促進因素與抑制因素
    • 市場促進因素
    • 市場抑制因素
  • 2018-2023 年全球市場規模表現與成長
  • 全球市場規模預測與成長，2023-2028、2033

第6章市場區隔

  • 全球呼吸道疾病檢測市場，依檢測類型細分、實際與預測，2018-2023、2023-2028、2033
  • 影像檢查
  • 機械測試
  • 體外診斷測試
  • 全球呼吸系統疾病檢測市場，依產品、性能及預測細分，2018-2023、2023-2028、2033
  • 肺容量
  • 影像
  • 肺活量測定法
  • 尖峰流量
  • 血氣
  • 其他產品
  • 全球呼吸系統疾病檢測市場，按應用、性能和預測細分，2018-2023、2023-2028、2033
  • 慢性阻塞性肺病
  • 肺癌
  • 氣喘
  • 結核病婦女
  • 其他用途
  • 全球呼吸系統疾病檢測市場，依最終用戶細分，實際與預測，2018-2023、2023-2028、2033
  • 醫院
  • 醫生辦公室
  • 臨床實驗室
  • 其他最終用戶

第 7 章 區域與國家分析

  • 全球呼吸系統疾病檢測市場，按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球呼吸系統疾病檢測市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 呼吸系統疾病偵測市場競爭形勢
  • 呼吸系統疾病檢測市場公司概況
    • Medtronic plc
    • Carestream Medical Ltd.
    • Abbott Laboratories
    • Siemens Healthineers AG
    • Koninklijke Philips NV

第31章競爭基準化分析

第 32 章競爭對手儀表板

第33章 重大併購

第34章 未來前景與可能性分析

第35章附錄

簡介目錄
Product Code: r12048

“Respiratory Disease Testing Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on respiratory disease testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for respiratory disease testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The respiratory disease testing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Test Type: Imaging Tests; Mechanical Tests; In-Vitro Diagnostic Tests
  • 2) By Products: Lung Volume; Imaging; Spirometry; Peak Flow; Blood Gas; Other Products
  • 3) By Application: Chronic Obstructive Pulmonary Disease; Lung Cancer; Asthma; Tuberculosis Female; Other Application
  • 4) By End-User: Hospitals; Physician clinics; Clinical laboratories; Other End-User
  • Companies Mentioned: Medtronic plc; Carestream Medical Ltd.; Abbott Laboratories; Siemens Healthineers AG; Koninklijke Philips N.V.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Respiratory disease testing encompasses the diagnostic process of evaluating various respiratory conditions through physical examinations. This procedure aids in the identification and measurement of lung conditions, assessing the speed at which a patient can exhale air. The results of these tests can assist clinicians in diagnosing respiratory diseases, even before patients exhibit symptoms.

The primary categories of tests involved in respiratory disease testing include imaging tests, mechanical tests, and in-vitro diagnostic tests. Imaging tests constitute a subset of diagnostic procedures that generate detailed images of various bodily regions. These tests utilize products such as lung volume imaging, spirometry, peak flow, blood gas, among others. They find applications in various respiratory conditions such as chronic obstructive pulmonary disease, lung cancer, asthma, and tuberculosis. These tests are typically conducted in hospitals, physician clinics, clinical laboratories, and other healthcare settings.

The respiratory disease testing market research report is one of a series of new reports from The Business Research Company that provides respiratory disease testing market statistics, including respiratory disease testing industry global market size, regional shares, competitors with a respiratory disease testing market share, detailed respiratory disease testing market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory disease testing industry. This respiratory disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The respiratory disease testing market size has grown steadily in recent years. It will grow from $3.42 billion in 2023 to $3.58 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The expansion observed during the historical period can be attributed to a confluence of factors, including environmental considerations and pollution, the prevalence of the tobacco smoking epidemic, occupational respiratory hazards, awareness campaigns, and health education programs. Additionally, government initiatives geared towards disease control played a significant role in shaping the growth landscape during this timeframe.

The respiratory disease testing market size is expected to see steady growth in the next few years. It will grow to $4.31 billion in 2028 at a compound annual growth rate (CAGR) of 4.8%. Anticipated growth in the forecast period can be attributed to several key factors, including the rise in airborne respiratory viruses, a heightened emphasis on home-based testing solutions, increased research in precision medicine, persistent environmental health concerns, and a focus on early intervention and prevention. Noteworthy trends expected during this period encompass the adoption of point-of-care testing, the integration of artificial intelligence (AI), the utilization of remote monitoring technologies, the expansion of telehealth services, the development of customized biomarker panels, and the enhancement of breath analysis techniques.

The upward trajectory in the prevalence of respiratory diseases is poised to significantly boost the respiratory disease testing market in the foreseeable future. Respiratory diseases encompass medical conditions affecting the respiratory system, including the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. The primary purpose of respiratory disease testing is early detection and diagnosis, facilitating prompt treatment and management. This proactive approach not only helps impede disease progression but is also crucial for controlling the transmission of infectious respiratory diseases and reducing the risk of complications. For instance, in September 2022, data from the NCD Alliance revealed that lung cancer ranked as the leading cause of global cancer deaths, with an anticipated 2.2 million new cases and 1.8 million fatalities annually. Chronic respiratory disorders affected 550 million adults globally, resulting in 4.2 million deaths, accounting for 7% of the total. Therefore, the rising prevalence of respiratory diseases is a key driver for the respiratory disease testing market.

The growing incidence of tobacco smoking is expected to further propel the growth of the respiratory disease testing market. Tobacco smoking, involving the inhalation of smoke produced by burning dried tobacco leaves, has a significant impact on respiratory health. Respiratory disease testing becomes essential in the care of tobacco smokers, enabling healthcare professionals to monitor changes in lung function over time. This monitoring aids in assessing the effectiveness of smoking cessation efforts and adjusting treatment plans accordingly. For example, data from the Centers for Disease Control and Prevention in May 2023 indicated that approximately 28.3 million adults aged 18 years or older in the U.S. were cigarette smokers, and around 16 million Americans were living with smoking-related diseases in 2021. As such, the growing incidence of tobacco smoking stands as a driving force behind the expansion of the respiratory disease testing market.

Technological advancements are emerging as a prominent trend in the respiratory disease testing market, with major companies focusing on innovative solutions to enhance treatment protocols and elevate patient outcomes. A notable example is Respira Labs, a U.S.-based healthcare technology company, which introduced the AI-powered wearable device, Sylvee, in March 2022. Sylvee, worn as a chest strap, employs artificial intelligence and machine learning algorithms to analyze data from multiple sensors measuring breathing rate, volume, and patterns. This device aids in the early diagnosis and management of conditions such as chronic obstructive pulmonary disease (COPD), asthma, and COVID-19, utilizing advanced AI algorithms to analyze breath sounds and provide real-time feedback on lung function.

Major players in the respiratory disease testing market are actively engaged in developing advanced products, such as pulmonary function testing, to establish a competitive advantage. A case in point is Vitalograph Ltd., a UK-based provider of respiratory diagnostics, which launched the VitaloPFT series in March 2023. This series offers detailed pulmonary function testing options, providing healthcare providers with a cost-effective solution for advanced respiratory diagnostics. Its user-friendly design simplifies the testing process, enhancing accessibility for healthcare professionals.

In January 2023, CAIRE Inc., a prominent U.S.-based medical supply and manufacturing company, completed the acquisition of MGC Diagnostics Holdings for an undisclosed amount. This strategic move is driven by CAIRE Inc.'s objective to expand the scope of its product line, diversify its income streams, and fortify its position as a leading player in the medical technology sector, specifically focusing on respiratory and cardiorespiratory diagnostics. MGC Diagnostics Holdings Inc., the acquired entity, is a U.S.-based medical technology company specializing in offering comprehensive cardiorespiratory diagnostic solutions and respiratory disease testing products.

Major companies operating in the respiratory disease testing market report are Medtronic plc, Carestream Medical Ltd., Abbott Laboratories, Seimens Healthineers AG, Koninklijke Philips N.V., ResMed Inc., Thermo Fisher Scientific Inc., Beckton Dickinson And Company, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, GE HealthCare Technologies Inc., Merck And Co. Inc., Fisher And Paykel Healthcare Corporation Limited, Qiagen N.V., Medical Graphics Corporation, COSMED srl, ndd Medizintechnik AG, Vitalograph Ltd., MGC Diagnostics Corporation, Vyaire Medical Inc., Smiths Medical International Ltd., Masimo Corporation, Hamilton Medical AG, Dragerwerk AG & Co. KGaA, Hill-Rom Holdings Inc., OSI Systems Inc., Schiller AG, Baxter International Inc., Nonin Medical Inc., Viasys Healthcare Inc., Natus Medical Incorporated

North America was the largest region in the respiratory disease testing market in 2023. Asia-Pacific is expected to be the fastest growing region in the global respiratory disease testing market during the forecast period. The regions covered in the respiratory disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the respiratory disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The respiratory disease testing market includes revenues earned by entities by providing services such as exhaled nitric oxide tests lung function tests. oxygen therapy, bronchoscopy, ultrasonography, nuclear lung scanning, and pulmonary artery angiography. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Respiratory Disease Testing Market Characteristics

3. Respiratory Disease Testing Market Trends And Strategies

4. Respiratory Disease Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Respiratory Disease Testing Market Size and Growth

  • 5.1. Global Respiratory Disease Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Respiratory Disease Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Respiratory Disease Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Respiratory Disease Testing Market Segmentation

  • 6.1. Global Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Imaging Tests
  • Mechanical Tests
  • In-Vitro Diagnostic Tests
  • 6.2. Global Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Lung Volume
  • Imaging
  • Spirometry
  • Peak Flow
  • Blood Gas
  • Other Products
  • 6.3. Global Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Chronic Obstructive Pulmonary Disease
  • Lung Cancer
  • Asthma
  • Tuberculosis Female
  • Other Application
  • 6.4. Global Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Physician clinics
  • Clinical laboratories
  • Other End-User

7. Respiratory Disease Testing Market Regional And Country Analysis

  • 7.1. Global Respiratory Disease Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Respiratory Disease Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Respiratory Disease Testing Market

  • 8.1. Asia-Pacific Respiratory Disease Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Respiratory Disease Testing Market

  • 9.1. China Respiratory Disease Testing Market Overview
  • 9.2. China Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Respiratory Disease Testing Market

  • 10.1. India Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Respiratory Disease Testing Market

  • 11.1. Japan Respiratory Disease Testing Market Overview
  • 11.2. Japan Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Respiratory Disease Testing Market

  • 12.1. Australia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Respiratory Disease Testing Market

  • 13.1. Indonesia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Respiratory Disease Testing Market

  • 14.1. South Korea Respiratory Disease Testing Market Overview
  • 14.2. South Korea Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Respiratory Disease Testing Market

  • 15.1. Western Europe Respiratory Disease Testing Market Overview
  • 15.2. Western Europe Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Respiratory Disease Testing Market

  • 16.1. UK Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Respiratory Disease Testing Market

  • 17.1. Germany Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Respiratory Disease Testing Market

  • 18.1. France Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Respiratory Disease Testing Market

  • 19.1. Italy Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Respiratory Disease Testing Market

  • 20.1. Spain Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Respiratory Disease Testing Market

  • 21.1. Eastern Europe Respiratory Disease Testing Market Overview
  • 21.2. Eastern Europe Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Respiratory Disease Testing Market

  • 22.1. Russia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Respiratory Disease Testing Market

  • 23.1. North America Respiratory Disease Testing Market Overview
  • 23.2. North America Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Respiratory Disease Testing Market

  • 24.1. USA Respiratory Disease Testing Market Overview
  • 24.2. USA Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Respiratory Disease Testing Market

  • 25.1. Canada Respiratory Disease Testing Market Overview
  • 25.2. Canada Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Respiratory Disease Testing Market

  • 26.1. South America Respiratory Disease Testing Market Overview
  • 26.2. South America Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Respiratory Disease Testing Market

  • 27.1. Brazil Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Respiratory Disease Testing Market

  • 28.1. Middle East Respiratory Disease Testing Market Overview
  • 28.2. Middle East Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Respiratory Disease Testing Market

  • 29.1. Africa Respiratory Disease Testing Market Overview
  • 29.2. Africa Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Respiratory Disease Testing Market Competitive Landscape And Company Profiles

  • 30.1. Respiratory Disease Testing Market Competitive Landscape
  • 30.2. Respiratory Disease Testing Market Company Profiles
    • 30.2.1. Medtronic plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Carestream Medical Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Siemens Healthineers AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Koninklijke Philips N.V
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Respiratory Disease Testing Market Competitive Benchmarking

32. Global Respiratory Disease Testing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Respiratory Disease Testing Market

34. Respiratory Disease Testing Market Future Outlook and Potential Analysis

  • 34.1 Respiratory Disease Testing Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Respiratory Disease Testing Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Respiratory Disease Testing Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer